Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2026 08:00 ET | Source: Atsena Therapeutics

Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Six-month data from adult Cohort 4 show structural and functional improvements and a favorable safety profile; early safety data from pediatric Cohort 5 are consistent with adult cohorts Enrollment...
May 04, 2026 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older

RAMSEY, N.J. and BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company...
May 04, 2026 06:31 ET | Source: TIP Knowledge Services Pvt. Ltd.

Eye Allergy Treatment Market to Surpass $5.97 Billion by 2031, Fueled by Increasing Eye Allergy Prevalence: Industry Research by The Insight Partners.

New York, NY, May 04, 2026 (GLOBE NEWSWIRE) -- A new comprehensive market research report published by The Insight Partners reveals that the Global Eye Allergy Treatment Market is projected to grow...
May 04, 2026 06:00 ET | Source: Scilex Holding Company

Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of April 30, 2026

PALO ALTO, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and...
May 03, 2026 16:52 ET | Source: Neuro Salt

Neuro Salt Under Investigation: Full "Pink Salt Trick" Consumer Report Reveals Shocking Hidden Risks

New York City, NY, May 03, 2026 (GLOBE NEWSWIRE) -- Neuro Salt has emerged as the supplement most prominently associated with the viral "Pink Salt Trick" concept, a phrase that in 2026 has...
May 01, 2026 17:11 ET | Source: Lean for Good

LeanBiome Claims Evaluated: The Lean For Good Biome Supplement Ingredients Under Investigation

LeanBiome ingredients evaluated: Lean for Good Biome® probiotic strains, gut microbiome formula, CFU count, refund policy, and official site reviewed.
May 01, 2026 16:05 ET | Source: InspireMD Inc.

InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System

MIAMI, May 01, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today...
May 01, 2026 16:05 ET | Source: InspireMD Inc.

InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System

- Strong clinical demand continues in Q1 2026 with global year-over-year unit sales growth of 53% and quarter-over-quarter U.S. unit sales growth of 34% - - FDA approval anticipated with U.S. market...
May 01, 2026 12:15 ET | Source: Rezolute, Inc.

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting

Includes results from additional continuous glucose monitoring (CGM)-based outcomes which demonstrate significant and consistent improvements in glycemic control in ersodetug treatment arms compared...
May 01, 2026 11:36 ET | Source: ITS Logistics

ITS Logistics Distribution + Fulfillment Q1 Index: Rising Transportation Costs Test Lean Inventory Strategies

RENO, Nev., May 01, 2026 (GLOBE NEWSWIRE) -- ITS Logistics today released the Q1 ITS Logistics U.S. Distribution and Fulfillment Index, Powered by Cresa. The index reveals that lean inventory...